Therapy News and Research

RSS

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its collaboration with the California Institute of Technology (Caltech) on a newly awarded $2.8 million Discovery Stage Research (DISC0) grant from the California Institute for Regenerative Medicine (CIRM).

14 Nov 2025

Enhancing the cancer-immunity cycle through innovative vaccines

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat malignancies.

14 Nov 2025

Transforming precision oncology with medical imaging foundation models

Medical imaging foundation models are ushering in a new era for precision oncology. By integrating massive multimodal datasets and advanced AI algorithms, these models achieve unprecedented accuracy in early cancer screening, treatment planning, and prognosis prediction.

14 Nov 2025

Self-hypnosis cuts menopausal hot flashes by half

Self-administered hypnosis effectively alleviates hot flashes in menopausal women, enhancing quality of life and providing an alternative to hormone therapy.

14 Nov 2025

Mental navigation framework helps people change pathological thinking

The stereotypical image of psychotherapy shows a patient lying on a couch, exploring their deepest traumas. This leads to awareness of unconscious habits, thoughts, and drives and has long been a cornerstone of psychotherapy.

14 Nov 2025

Automated insulin delivery improves glucose control in pregnant women with Type 1 diabetes

An international study co-led by University of Calgary researchers has found new insulin delivery technology helps control glucose levels during pregnancy for those with Type 1 diabetes, which is crucial to the health of women and their newborns.

13 Nov 2025

Revised ESE clinical guideline published for the management of hypoparathyroidism in adults

The European Society of Endocrinology (ESE) has published an open access Revised Clinical Practice Guideline for the Treatment of Chronic Hypoparathyroidism in Adults in the European Journal of Endocrinology, Volume 193, Issue 5, November 2025.

13 Nov 2025

Lymphoma resistance mechanisms and future therapies

A new review was published in Volume 12 of Oncoscience on October 13, 2025, titled "Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions."

13 Nov 2025

Research provides new insights into postoperative risk stratification for ampullary adenocarcinoma

Despite advances in cancer care, treatment strategies for ampullary adenocarcinoma (AAC) remain uncertain. Its anatomic location and biological diversity lead to variable clinical behavior and outcomes.

13 Nov 2025

Single-cell study reveals how HPV shapes immune landscape in penile cancer

Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with a five-year survival rate near 50%.

13 Nov 2025

Carolina Molecular partners with Pixelgen, becomes first US certified service provider for Pixelgen Proxiome Kit - Pixelgen Technologies

Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced today a partnership to expand access to cutting-edge 3D protein interactomics capabilities to researchers and clinicians in the United States. Carolina Molecular will be the first certified U.S. service provider for Pixelgen.

13 Nov 2025

Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve chronic disease outcomes for at-risk patients, today announced a collaboration with a leading global pharmaceutical company recognized for its expertise in precision medicine and biomarker-guided drug development.

From Mursla Bio 13 Nov 2025

Celleo Biotech uses INTEGRA's PIPETBOY GENIUS to improve reproducibility and efficiency

Celleo Biotech is using the PIPETBOY GENIUS serological pipet controller from INTEGRA Biosciences to streamline the development and manufacturing of novel cell and gene therapies.

From INTEGRA Biosciences 13 Nov 2025

Research identifies factors for long-term myeloma remission

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see their cancer return sooner.

13 Nov 2025

Therapy News and Research

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

Enhancing the cancer-immunity cycle through innovative vaccines

Transforming precision oncology with medical imaging foundation models

Self-hypnosis cuts menopausal hot flashes by half

Mental navigation framework helps people change pathological thinking

Automated insulin delivery improves glucose control in pregnant women with Type 1 diabetes

Revised ESE clinical guideline published for the management of hypoparathyroidism in adults

Lymphoma resistance mechanisms and future therapies

Research provides new insights into postoperative risk stratification for ampullary adenocarcinoma

Single-cell study reveals how HPV shapes immune landscape in penile cancer

Carolina Molecular partners with Pixelgen, becomes first US certified service provider for Pixelgen Proxiome Kit - Pixelgen Technologies

Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH

Celleo Biotech uses INTEGRA's PIPETBOY GENIUS to improve reproducibility and efficiency

Research identifies factors for long-term myeloma remission

Collaborative effort advances next-generation therapies for pancreatic and GI cancers

New Mayo Clinic tool predicts Alzheimer’s risk years before symptoms begin

Breakthroughs in theranostic nanomaterials for traumatic brain injury management

Understanding thrombocytopenia in patients with portal hypertension and chronic liver disease

New research supports general anesthesia as an option for cesarean births

Study finds self-pleasure as a valuable care strategy for managing menopause symptoms

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News